According to the new market research report “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023", published by MarketsandMarkets™, The global autoinjectors market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023). The key factors driving the growth of this market include the growing prevalence of targeted therapies such as rheumatoid arthritis and multiple sclerosis, rising incidence of anaphylaxis, and increasing number of regulatory approvals.

Don’t miss out on business opportunities in Autoinjectors Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2yLmTi3
Early buyers will receive 10% customization on reports.

[133 Pages Report] The global autoinjectors market was valued at USD 25.84 billion in 2017 and is projected to reach USD 85.31 billion by 2023, at a CAGR of 24.2% during the forecast period. Base year considered for the report is 2017 and the forecast period considered for this report is 2018–2023.

Objectives of the Study
To define, measure, and describe the global autoinjectors market by therapy, type, end user, and region
To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW
To strategically analyze the market structure and profile key players in the global autoinjectors market and comprehensively analyze their core competencies
To track and analyze company developments such as partnerships, agreements, and collaborations; expansions; product approvals; and product launches in the autoinjectors market
Browse and in-depth TOC on “Autoinjectors Market”
66 - Tables

36 - Figures

133 - Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/autoinjector-market-173991724.html

Geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American region is expected to account for the largest share of the market in 2018. The large share of this region can be attributed to the rising prevalence of autoimmune and chronic diseases, rising prevalence of anaphylaxis, and favorable reimbursement scenario in this region.

Preference for alternative drug delivery modes such as oral diabetic agents and epinephrine nasal sprays is expected to restrain the growth of this market during the forecast period to a certain extent.

The major players in the global autoinjectors market are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US). The other prominent players are Merck (US), SHL Group (Taiwan), Ypsomed (Switzerland), AstraZeneca (UK), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), J&J (US), and Haselmeier (Switzerland).

Request for Free Sample Report @ http://bit.ly/2EE4muv

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting
About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/autoinjector-market.asp

Visit Our Website: https://www.marketsandmarkets.com